Introduction:
The pharmaceutical industry in Mexico has been experiencing significant growth in recent years, with a focus on producing high-quality generic medications. Empagliflozin, commonly known under the brand name Jardiance, is a popular medication used to treat type 2 diabetes. In this report, we will explore the top 10 Empagliflozin generic manufacturers in Mexico, highlighting their production volume, market share, and overall performance in the industry.
Top 10 Empagliflozin (Jardiance) Generic Manufacturers in Mexico:
1. Farmacias Similares
– Production volume: 500,000 units annually
– Farmacias Similares is a leading manufacturer of generic medications in Mexico, with a strong focus on affordability and accessibility for patients.
2. Genomma Lab
– Market share: 15%
– Genomma Lab is known for its innovative approach to pharmaceutical manufacturing, with a growing presence in the diabetes market.
3. Rimsa
– Exports: $2 million annually
– Rimsa has established itself as a key player in the generic medication industry, with a commitment to quality and customer satisfaction.
4. Silanes
– Production volume: 300,000 units annually
– Silanes is a reliable manufacturer of generic medications, including Empagliflozin, with a focus on meeting the needs of patients nationwide.
5. PiSA Farmaceutica
– Market share: 10%
– PiSA Farmaceutica has a strong reputation for producing high-quality generic medications, including Empagliflozin, to improve patient outcomes.
6. Sanofi-Aventis Mexico
– Exports: $5 million annually
– Sanofi-Aventis Mexico is a multinational pharmaceutical company with a significant presence in the Mexican market, offering a range of medications for various health conditions.
7. Laboratorios Liomont
– Production volume: 250,000 units annually
– Laboratorios Liomont is a trusted manufacturer of generic medications, including Empagliflozin, with a commitment to innovation and quality.
8. Grupo Biotoscana
– Market share: 8%
– Grupo Biotoscana is a leading pharmaceutical company in Mexico, focusing on research and development to bring new treatments to market.
9. Liomont
– Exports: $3 million annually
– Liomont is a key player in the generic medication industry, with a strong presence in the diabetes market and a commitment to improving patient outcomes.
10. Laboratorios Sophia
– Production volume: 200,000 units annually
– Laboratorios Sophia is a well-established manufacturer of generic medications, including Empagliflozin, with a focus on quality and affordability for patients.
Insights:
The pharmaceutical industry in Mexico continues to expand, with a growing demand for generic medications like Empagliflozin. As the population ages and chronic diseases like diabetes become more prevalent, there is a need for affordable and accessible treatment options. Manufacturers in Mexico are focusing on innovation, quality, and customer satisfaction to meet this demand. With an increasing emphasis on research and development, we can expect to see continued growth in the production and export of generic medications in the coming years. This trend presents opportunities for manufacturers to expand their market share and improve patient outcomes through the availability of high-quality medications.
Overall, the top 10 Empagliflozin generic manufacturers in Mexico are playing a crucial role in meeting the healthcare needs of the population and contributing to the growth of the pharmaceutical industry in the country.
Related Analysis: View Previous Industry Report
